{
  "docId": "019de074-f95f-763f-9a80-be3b653e0df1",
  "docSlug": "502ed4e7545b260f09647399e486ae2c",
  "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 28 slides",
  "authorId": "matinas-biopharma",
  "authorName": "Matinas BioPharma",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 10,
  "pageCount": 28,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "why_now",
  "function": "argue_timing",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "Uses WHO priority pathogen list as an external validation/market driver for the company's pipeline.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-f95f-763f-9a80-be3b653e0df1/10",
  "deckHref": "/decks/019de074-f95f-763f-9a80-be3b653e0df1",
  "deckJsonHref": "/decks/019de074-f95f-763f-9a80-be3b653e0df1.json",
  "deckAnchorHref": "/decks/019de074-f95f-763f-9a80-be3b653e0df1#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.45,
        "w": 0.13,
        "x": 0.21,
        "y": 0.39
      },
      "kind": "image",
      "text": "WHO report cover",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a3d36021-c7a1-4e06-a467-912666cd4863",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.15,
        "x": 0.05,
        "y": 0.49
      },
      "kind": "image",
      "text": "World Health Organization",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5e746f7d-b8e9-4da2-b32f-e378434881fe",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.5,
        "x": 0.42,
        "y": 0.66
      },
      "kind": "list",
      "text": "HIGH PRIORITY: Mucormycosis: Preclinical data",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "131969de-64ae-4a41-96ba-7b415cb68cc7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.5,
        "x": 0.42,
        "y": 0.34
      },
      "kind": "list",
      "text": "CRITICAL PRIORITY: Cryptococcal meningitis: Phase 2 success and QIDP; Aspergillosis: Preclinical data and QIDP",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c1036cb8-9a6d-43c2-9ff1-3cbb1dca46ff",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.53,
        "x": 0.42,
        "y": 0.19
      },
      "kind": "paragraph",
      "text": "Matinas is leveraging the safety and efficacy of MAT2203 to meet the needs of both critical and high priority groups identified by WHO",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0cd537c9-e8dd-4bf2-8a8a-6e27d0f65107",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.33,
        "x": 0.05,
        "y": 0.19
      },
      "kind": "paragraph",
      "text": "The World Health Organization (WHO) released its first fungal priority pathogens list to guide research and development",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "76fc52d2-ebc2-49df-9b5d-1b6f56cdcc91",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.25,
        "x": 0.05,
        "y": 0.87
      },
      "kind": "source-note",
      "text": "1:https://www.who.int/publications/i/item/9789240060241",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cfb54023-e0ae-44ab-a807-31d00c2e16a2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.55,
        "x": 0.02,
        "y": 0.06
      },
      "kind": "title",
      "text": "Addressing Emerging Threats From Fungal Infections",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c0eb219c-a76a-42fb-88ab-632cc1f0fb5a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 10,
      "from": 9,
      "beatId": "fc12abb3-5592-41fa-bb0f-73538310f56b",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "The deck presents the problem of serious and life-threatening fungal infections.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 12,
      "from": 10,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "c50fa4d6-4f37-4861-9ddc-c482a0ce90ef",
      "evidence": "The deck highlights the limitations of current treatment options and the potential benefits of MAT2203.",
      "position": 0,
      "objective": "What is the cost of not addressing the current limitations in treatment options?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 12,
      "from": 10,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "0540937d-e3f0-46a5-9468-eab2036e9b16",
      "evidence": "The deck presents the current state of the company and its future plans.",
      "position": 1,
      "objective": "Why is now the right time to invest in Matinas BioPharma?",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.6,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}